Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.8299
-0.0301 (-3.50%)
At close: Jun 27, 2025, 4:00 PM
0.8399
+0.0100 (1.20%)
After-hours: Jun 27, 2025, 7:18 PM EDT
Predictive Oncology Employees
As of December 31, 2024, Predictive Oncology had 24 total employees, including 23 full-time and 1 part-time employees. The number of employees decreased by 11 or -31.43% compared to the previous year.
Employees
24
Change (1Y)
-11
Growth (1Y)
-31.43%
Revenue / Employee
$72,053
Profits / Employee
-$453,684
Market Cap
7.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
POAI News
- 16 days ago - Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - GlobeNewsWire
- 4 weeks ago - Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewsWire
- 5 weeks ago - AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewsWire
- 5 weeks ago - Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" - GlobeNewsWire
- 6 weeks ago - Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewsWire
- 3 months ago - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewsWire